Q3 FY2026 · ended Sep 30, 2026 · Revenue $1.35B, +6.0% YoY · Filed Nov 2, 2026
Herbalife Ltd. (HLF) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $1.4 billion and net income of $58.8 million. Free cash flow was $132.8 million. As of Sep 30, 2026 it held $409.2 million in cash and investments and $2.1 billion in total debt.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- HLF (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- George Town, Cayman Islands
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1180262
- Former names
- HERBALIFE NUTRITION LTD. (until Apr 11, 2023); WH HOLDINGS CAYMAN ISLANDS LTD (until Dec 13, 2004)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.3B | $1.3B | $1.3B | $1.3B |
| Operating income | $138.5M | $128.3M | $138.4M | $99.8M | $125.8M |
| Net income | $58.8M | -$26.3M | $61.9M | $85.4M | $43.2M |
| Diluted EPS | $0.55 | -$0.25 | $0.57 | $0.82 | $0.42 |
| Operating cash flow | $151.3M | $32.9M | $113.8M | $98.3M | $138.8M |
| Free cash flow | $132.8M | $21.6M | $102.9M | $79.8M | $118.0M |
| Total assets | $2.9B | $2.9B | $2.9B | $2.8B | $2.7B |
| Total liabilities | $3.3B | $3.3B | $3.3B | $3.3B | $3.3B |
| Stockholders' equity | -$409.6M | -$474.5M | -$441.5M | -$515.1M | -$612.0M |
| Cash and investments | $409.2M | $370.5M | $451.2M | $353.1M | $305.5M |
| Total debt | $2.1B | $2.2B | $2.2B | $2.2B | $2.2B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2026 | Nov 2, 2026 |
| 10-Q | Quarterly report | Nov 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 31, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 5, 2026 | Jul 30, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Shareholder vote results, Regulation FD disclosure
|
May 6, 2026 | Apr 30, 2026 |
All 1003 Herbalife Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.